Short-term treatment of catatonia with amantadine in schizophrenia and schizoaffective disorder

J Clin Psychopharmacol. 2012 Aug;32(4):569-72. doi: 10.1097/JCP.0b013e31825ebf6e.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Amantadine / therapeutic use*
  • Catatonia / complications
  • Catatonia / drug therapy*
  • Female
  • Humans
  • Male
  • Psychotic Disorders / complications
  • Psychotic Disorders / drug therapy*
  • Receptors, N-Methyl-D-Aspartate / antagonists & inhibitors
  • Schizophrenia / complications
  • Schizophrenia / drug therapy*

Substances

  • Receptors, N-Methyl-D-Aspartate
  • Amantadine